Live stream: COVID-19 and mental health: What happened and what's next?

Dr Joan Marsh is the Editor-in-Chief of The Lancet Psychiatry. She joined the Lancet group in November 2013 as Deputy Editor to help to launch The Lancet Psychiatry and continued in that role until November 2021. She now has overall responsibility for the journal and its development, which includes manuscript assessment, overseeing peer review, and commissioning content. Her particular project is the Editorial Board Development Programme. Joan read Natural Sciences at Cambridge University, then completed a PhD in molecular biology. She worked as an editor with The Ciba/Novartis Foundation in London, editing and organizing their prestigious symposium series. 

Joan then spent several years in South-East Asia, including two years in Hong Kong, where she worked for Hong Kong University and for Excerpta Medica. Joan returned to the UK in September 1999 and became an editor with John Wiley & Sons, commissioning books in the life sciences and medicine. Joan is actively engaged with the European Association of Science Editors. She was on the Council for 12 years, including six as President. She is now Chair of its Gender Policy Committee, with a particular interest in improving diversity in peer review. She is also an Associate Editor for the Association’s journal, European Science Editing.

Dr Harrison trained in medicine and psychiatry in Oxford and London, and was a Wellcome Trust Senior Research Fellow before being appointed to his present post in 1997. He heads a research group investigating molecular, psychopharmacological and therapeutic aspects of bipolar disorder and schizophrenia – and now the psychiatric and neurological aspects of COVID-19. He has published over 330 papers, and several books, including the Shorter Oxford Textbook of Psychiatry, and Schizophrenia (with Daniel Weinberger). Dr Harrison is a Theme Leader in the NIHR Oxford Health Biomedical Research Centre, and an investigator in the Wellcome Centre for Integrative Neuroimaging. He has served on various funding committees, the REF2021 subpanel 4, and chaired an NHS Research Ethics Committee. Awards include the CINP/Paul Janssen Schizophrenia Prize (1998), the British Association for Psychopharmacology Senior Clinical Prize (1999), the A.E. Bennett Award of the Society of Biological Psychiatry (2004), the Joel Elkes Research Award of the American College of Neuropsychopharmacology (2005), the CINP Lilly Clinical Neuroscience award (2010), and the ECNP Clinical Neuropsychopharmacology award (2012). Dr Harrison was President of the British Association for Psychopharmacology from 2014-2016.